Clinical Trials Directory

Trials / Unknown

UnknownNCT01089959

Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD

The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With Gastroesophageal Reflux Disease (GERD).

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Southern Arizona VA Health Care System · Federal
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if esomeprazole 40 mg. once daily improves not only nighttime symptoms but also significantly reduces conscious awakenings associated with gastroesophageal reflux and consequently improves sleep quality.

Detailed description

Twenty GERD patients with nighttime heartburn and/or regurgitation at least 3 times a week will be invited to participate in the study. All patients will undergo upper endoscopy to determine presence or absence of esophageal inflammation(using Los Angeles criteria). All patients will be evaluated by the Demographic,Berlin,Epworth Sleepiness Scale Questionnaires, and GERD Symptom Checklist. Thereafter,patients will undergo pH testing w/ an actigraph.The morning of pH probe removal,a Sleep Quality Questionaire will be administered. Subjects will then receive esomeprazole 40 mg. once daily(30 minutes before breakfast) for 1 week. On day 7,subjects will again undergo pH testing w/ actigraphy, and the results will be analyzed again w/ new integrative software. On the morning of pH probe removal, the sleep Quality Questionnaire will be re-administered.

Conditions

Interventions

TypeNameDescription
DRUGEsomeprazole40 mg daily for 7 days
DRUGesomeprazole40 mg. daily, oral medication, once daily for 7 days.

Timeline

Start date
2010-03-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2010-03-19
Last updated
2010-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01089959. Inclusion in this directory is not an endorsement.